RecruitingPhase 3NCT06523400
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2
Studying Proximal myotonic myopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lupin Ltd.
- Intervention
- Mexiletine granules for prolonged-release oral suspension(drug)
- Enrollment
- 176 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2025 – 2026
Study locations (7)
- Laboratory for Muscle Diseases and Neuropathies, Leuven, Belgium
- Aarhus University Hospital, Aarhus, Denmark
- Ludug-Maximilians University, München, Germany
- Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Rome, Italy
- University Hospital of Madrid, Madrid, Spain
- Saint George's University Hospitals NHS Foundation Trust, London, United Kingdom
- University College Hospital, London, United Kingdom
Collaborators
Lupin Atlantis Holdings S.A.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06523400 on ClinicalTrials.govOther trials for Proximal myotonic myopathy
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT06549400An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.Lupin Ltd.
- RECRUITINGPHASE1, PHASE2NCT06844214A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1Sanofi
- RECRUITINGNANCT06716931Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)Massachusetts General Hospital
- RECRUITINGNCT05854433Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2Wake Forest University Health Sciences
- RECRUITINGNCT04003363The United Kingdom National Registry for Myotonic DystrophyNewcastle University
- RECRUITINGNCT02398786Myotonic Dystrophy Family RegistryMyotonic Dystrophy Foundation
- RECRUITINGNCT00082108Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy RegistryUniversity of Rochester